Product DNN.63.18.040: Clinical Trials

1 trial of Product DNN.63.18.040, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Not yet recruiting 1

Follow Product DNN.63.18.040: new trials by email Literature Review of Product DNN.63.18.040 trials Research Report on Product DNN.63.18.040

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of DNN.63.18.040 for the Treatment of Moderate to Severe Pain
Product DNN.63.18.040, TramalĀ® - Acute Pain
Phase 3Not yet recruitingAche Laboratorios Farmaceuticos S.A.3702026-10-192026-10-19

Conditions studied

Acute Pain (1)

Sponsors

Ache Laboratorios Farmaceuticos S.A. (1)